•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy
PTC's Creo and Windchill Solutions Selected for Product Development across Fisica Applied Technologies
PTC Inc.: The Market Is Pricing In Stagnation At 16x Earnings
Amundi Has $107.65 Million Stock Position in PTC Inc. $PTC
PTC Inc. (PTC) Presents at Citi's 2026 Global TMT Conference Transcript
Hsbc Holdings PLC Purchases 231,563 Shares of PTC Inc. $PTC
PTC Inc. (PTC) Up 16.6% Since Last Earnings Report: Can It Continue?
PTC Therapeutics to Participate in Upcoming Investor Conferences
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
PTC Therapeutics: An Acquisition Which Could Unlock Massive Potential
PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal
PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'
PTC Advances Leadership in AI-Driven Design with Launch of Onshape FeatureScript MCP Server
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
PTC Inc. (NASDAQ:PTC) Receives Average Recommendation of “Hold” from Brokerages
Bank of America Corp DE Sells 39,720 Shares of PTC Inc. $PTC
Is It Too Late to Buy PTC Inc (PTC) After 5.9% Rally? GF Value Says Undervalued
PTC Strengthens ALM Portfolio with New AI and Configuration Management Capabilities for Enterprise Complexity
PTC Will Participate in Upcoming Investor Conferences